S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
Log in

NASDAQ:VVUSVIVUS News Headlines

$1.29
-0.02 (-1.53 %)
(As of 04/7/2020 10:06 AM ET)
Add
Compare
Today's Range
$1.26
Now: $1.29
$1.33
50-Day Range
$0.89
MA: $1.57
$3.60
52-Week Range
$0.80
Now: $1.29
$4.75
Volume2,489 shs
Average Volume3.80 million shs
Market Capitalization$13.74 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.03

Headlines

VIVUS (NASDAQ VVUS) News Headlines

Source:
DateHeadline
VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules - Yahoo FinanceVitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules - Yahoo Finance
finance.yahoo.com - April 3 at 3:27 PM
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo FinanceVIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo Finance
finance.yahoo.com - April 3 at 3:27 PM
VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring ModulesVitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules
finance.yahoo.com - April 3 at 3:27 PM
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesVIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - April 3 at 3:27 PM
Vivus down 55% on equity offeringVivus down 55% on equity offering
seekingalpha.com - April 3 at 7:47 AM
BRIEF-Sabby Management Reports 9.97% Passive Stake In Vivus Inc As Of April 1 - SEC Filing - ReutersBRIEF-Sabby Management Reports 9.97% Passive Stake In Vivus Inc As Of April 1 - SEC Filing - Reuters
www.reuters.com - April 1 at 3:59 PM
BRIEF-Vivus Announces $11.55 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - ReutersBRIEF-Vivus Announces $11.55 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Reuters
www.reuters.com - April 1 at 3:59 PM
Why Vivus Is Trading Lower Today - BenzingaWhy Vivus Is Trading Lower Today - Benzinga
www.benzinga.com - April 1 at 3:59 PM
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo FinanceVIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo Finance
finance.yahoo.com - April 1 at 3:59 PM
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesVIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - April 1 at 3:59 PM
EYEG Catches Eyes, KNSA & COVID-19, VVUS Gains Weight On Launch Of Telemedicine - NasdaqEYEG Catches Eyes, KNSA & COVID-19, VVUS Gains Weight On Launch Of Telemedicine - Nasdaq
www.nasdaq.com - April 1 at 7:26 AM
Vivus Shares Rally On Accelerated Telemedicine Launch - BenzingaVivus Shares Rally On Accelerated Telemedicine Launch - Benzinga
www.benzinga.com - April 1 at 2:26 AM
U.S. dollar rises, but off highs, as Fed measures weigh - NasdaqU.S. dollar rises, but off highs, as Fed measures weigh - Nasdaq
www.nasdaq.com - March 31 at 4:24 PM
Health Care Sector Update for 03/31/2020: MTNB,VVUS,ALPN,RETA - NasdaqHealth Care Sector Update for 03/31/2020: MTNB,VVUS,ALPN,RETA - Nasdaq
www.nasdaq.com - March 31 at 4:24 PM
Health Care Sector Update for 03/31/2020: VVUS,ALPN,RETA - NasdaqHealth Care Sector Update for 03/31/2020: VVUS,ALPN,RETA - Nasdaq
www.nasdaq.com - March 31 at 4:24 PM
Stock Traders Buy High Volume of Call Options on VIVUS (NASDAQ:VVUS)Stock Traders Buy High Volume of Call Options on VIVUS (NASDAQ:VVUS)
www.americanbankingnews.com - March 31 at 1:26 PM
5 Best Penny Stocks To Buy This Week? - Yahoo Finance5 Best Penny Stocks To Buy This Week? - Yahoo Finance
finance.yahoo.com - March 31 at 11:24 AM
VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing” - Yahoo FinanceVIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing” - Yahoo Finance
finance.yahoo.com - March 31 at 11:24 AM
VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”
finance.yahoo.com - March 31 at 11:24 AM
VIVUS, Inc. (NASDAQ:VVUS) Sees Large Increase in Short InterestVIVUS, Inc. (NASDAQ:VVUS) Sees Large Increase in Short Interest
www.americanbankingnews.com - March 28 at 10:01 AM
2020 Market Spotlight: Erectile Dysfunction - ResearchAndMarkets.com - Yahoo Finance2020 Market Spotlight: Erectile Dysfunction - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - March 20 at 5:43 PM
Global Erectile Dysfunction Market Assessment, 2026 - Yahoo FinanceGlobal Erectile Dysfunction Market Assessment, 2026 - Yahoo Finance
finance.yahoo.com - March 14 at 7:15 AM
Erectile Dysfunction Industry Report 2020: Epidemiology, Marketed & Pipeline Drugs, Revenue Opportunities, Clinical Trial Landscape - PRNewswireErectile Dysfunction Industry Report 2020: Epidemiology, Marketed & Pipeline Drugs, Revenue Opportunities, Clinical Trial Landscape - PRNewswire
www.prnewswire.com - March 13 at 4:14 PM
VIVUS, Inc. 424B5 Mar. 6, 2020 5:20 PM - Seeking AlphaVIVUS, Inc. 424B5 Mar. 6, 2020 5:20 PM - Seeking Alpha
seekingalpha.com - March 7 at 8:06 AM
Vivus -7.6% on filing to offer up to $50M in shares - Seeking AlphaVivus -7.6% on filing to offer up to $50M in shares - Seeking Alpha
seekingalpha.com - March 6 at 11:46 PM
VVUS: Fourth Quarter and Full Year 2019 Results - Yahoo FinanceVVUS: Fourth Quarter and Full Year 2019 Results - Yahoo Finance
finance.yahoo.com - March 5 at 8:05 PM
VIVUS, Inc. (VVUS) CEO VIVUS, Inc. on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaVIVUS, Inc. (VVUS) CEO VIVUS, Inc. on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 5 at 8:05 PM
VVUS: Fourth Quarter and Full Year 2019 ResultsVVUS: Fourth Quarter and Full Year 2019 Results
finance.yahoo.com - March 5 at 8:05 PM
VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results - StreetInsider.comVIVUS Reports Fourth Quarter and Full Year 2019 Financial Results - StreetInsider.com
www.streetinsider.com - March 5 at 10:03 AM
Edited Transcript of VVUS earnings conference call or presentation 3-Mar-20 9:30pm GMT - Yahoo FinanceEdited Transcript of VVUS earnings conference call or presentation 3-Mar-20 9:30pm GMT - Yahoo Finance
finance.yahoo.com - March 4 at 2:07 PM
Edited Transcript of VVUS earnings conference call or presentation 3-Mar-20 9:30pm GMTEdited Transcript of VVUS earnings conference call or presentation 3-Mar-20 9:30pm GMT
finance.yahoo.com - March 4 at 9:06 AM
Vivus: 4Q Earnings Snapshot - Yahoo FinanceVivus: 4Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - March 3 at 11:28 PM
VIVUS, Inc. (VVUS) CEO John Amos on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaVIVUS, Inc. (VVUS) CEO John Amos on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 3 at 11:28 PM
10 Stocks Moving In Tuesdays After-Hours Session - Benzinga10 Stocks Moving In Tuesday's After-Hours Session - Benzinga
www.benzinga.com - March 3 at 6:28 PM
VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswireVIVUS Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswire
www.globenewswire.com - March 3 at 6:28 PM
VIVUS Reports Fourth Quarter and Full Year 2019 Financial ResultsVIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 3 at 6:27 PM
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in Adolescents - GlobeNewswireVIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in Adolescents - GlobeNewswire
www.globenewswire.com - March 3 at 7:16 AM
BRIEF-VIVUS Completes Enrollment In Phase 4 Safety And Efficacy Study Of Qsymia In Adolescents - ReutersBRIEF-VIVUS Completes Enrollment In Phase 4 Safety And Efficacy Study Of Qsymia In Adolescents - Reuters
www.reuters.com - March 2 at 3:18 PM
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in Adolescents - Yahoo FinanceVIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in Adolescents - Yahoo Finance
finance.yahoo.com - March 2 at 3:18 PM
VIVUS (VVUS) Reports Complete Enrollment in Phase 4 Safety and Efficacy Study of Qsymia in Adolescents - StreetInsider.comVIVUS (VVUS) Reports Complete Enrollment in Phase 4 Safety and Efficacy Study of Qsymia in Adolescents - StreetInsider.com
www.streetinsider.com - March 2 at 3:18 PM
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in AdolescentsVIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in Adolescents
finance.yahoo.com - March 2 at 7:35 AM
Form 8-K VIVUS INC For: Feb 19 - StreetInsider.comForm 8-K VIVUS INC For: Feb 19 - StreetInsider.com
www.streetinsider.com - February 19 at 5:06 PM
BRIEF-Vivus Inc Launched Qsymia In Republic Of Korea With Alvogen, Cos Korean Marketing Partner - ReutersBRIEF-Vivus Inc Launched Qsymia In Republic Of Korea With Alvogen, Co's Korean Marketing Partner - Reuters
www.reuters.com - February 19 at 12:05 PM
VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream - Yahoo FinanceVIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream - Yahoo Finance
finance.yahoo.com - February 19 at 12:05 PM
Vivus up 4% premarket on Qsymia launch in Korea - Seeking AlphaVivus up 4% premarket on Qsymia launch in Korea - Seeking Alpha
seekingalpha.com - February 19 at 12:05 PM
VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue StreamVIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream
finance.yahoo.com - February 19 at 12:05 PM
VIVUS to Host Fourth Quarter Business Update and Financial Results Conference Call on Tuesday, March 3, 2020 - Yahoo FinanceVIVUS to Host Fourth Quarter Business Update and Financial Results Conference Call on Tuesday, March 3, 2020 - Yahoo Finance
finance.yahoo.com - February 18 at 12:27 PM
VIVUS to Host Fourth Quarter Business Update and Financial Results Conference Call on Tuesday, March 3, 2020VIVUS to Host Fourth Quarter Business Update and Financial Results Conference Call on Tuesday, March 3, 2020
finance.yahoo.com - February 18 at 12:27 PM
68 Stocks Moving In Wednesdays Mid-Day Session - Benzinga68 Stocks Moving In Wednesday's Mid-Day Session - Benzinga
www.benzinga.com - February 6 at 12:45 AM
VIVUS Receives U.S. Food and Drug Administration Approval for Improved Formulation of PANCREAZE® with a 36-Month Shelf Life - Yahoo FinanceVIVUS Receives U.S. Food and Drug Administration Approval for Improved Formulation of PANCREAZE® with a 36-Month Shelf Life - Yahoo Finance
finance.yahoo.com - February 5 at 2:44 PM
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel